Phase II study of hydroxyurea [hydroxycarbamide] in patients with recurrent and/or nonresectable meningioma [brain cancer].
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 23 Jul 2008
At a glance
- Drugs Hydroxycarbamide (Primary)
- Indications Brain cancer
- Focus Therapeutic Use
- 23 Sep 2005 New trial record.